Allergy

The Pharmacy Times® Allergy resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Antibiotic Allergies are Not Well-Documented

Study finds that few documented antibiotic allergies are correct, and family physicians and pharmacists do not have sufficient knowledge on the issue.

Palforzia From Aimmune Therapeutics Inc

Palforzia is an oral immunotherapy agent for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.

New Epinephrine Injection Granted FDA Approval

This generic drug product was determined by the FDA to be therapeutically equivalent to Adrenalin.

Interactives: Case Studies (April 2020)

Two retail pharmacy case studies are presented.

Novel Agents Can Treat Asthma

Pharmacists should understand their mechanisms to facilitate high-quality, collaborative management with physicians.

Rx Product News (April 2020)

Rx products features in the April 2020 issue.

OTC Products (April 2020)

Over-the-counter products featured in the April 2020 issue of Pharmacy Times.

Study: Milk Allergy Guidelines May Cause Overdiagnosis in Babies, Children

Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.

Patients are Being Treated for Peanut Allergy with New Immunotherapy

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

FDA Approves OTC Olopatadine Solutions for Eye Allergy Relief

The FDA has approved olopatadine hydrochloride ophthalmic 0.1% and 0.2% solution for sale as an OTC medication in the United States.

Eye Allergy Itch-Relief Drops to Be Available Over-the-Counter

The once-daily solution will be the first once-daily eye-itch allergy-relief drop to be available without a prescription in the United States.

First Drug Treatment for Peanut Allergy Receives FDA Approval

Treatment with this peanut immunotherapy consists of 3 phases: Initial Dose Escalation, Up-Dosing, and Maintenance.

The Pharmacy Times® Allergy resource center serves as the heart of all clinical news and articles related to allergies. The coverage includes updates from the floor of all the biggest societal conferences and annual meetings, as well as video interviews of the leading experts and key opinion leaders in allergy.

Among the multimedia content are breaking news coverage of approvals from the US Food and Drug Administration, key takeaways from the latest novel therapies in clinical trials, and notifications of updates to clinical guidelines for countless conditions. Additionally, this resource provides multiple allergen-specific resources, ranging from food and drug to environment and contact-based allergies.